Should Antithrombotic Treatment Strategies in East Asians Differ from Caucasians?-Reference-Cited by-同舟云学术

Should Antithrombotic Treatment Strategies in East Asians Differ from Caucasians?

Published:2018-07-10 Issue:5 Volume:16 Page:459-476
ISSN:1570-1611
Container-title:Current Vascular Pharmacology
language:en
Short-container-title:CVP

Author:

Bae Jae S.¹,Ahn Jong-Hwa¹,Tantry Udaya S.²,Gurbel Paul A.²,Jeong Young-Hoon¹

Affiliation:

1. Department of Internal Medicine, Gyeongsang National University, School of Medicine and Cardiovascular Center, Gyeongsang National University Changwon Hospital, Changwon, Korea

2. Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Fairfax, Virginia, United States

Publisher

Bentham Science Publishers Ltd.

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-dose prasugrel versus standard-dose ticagrelor in east Asian patients with acute coronary syndrome;Journal of Thrombosis and Thrombolysis;2024-03-31

2. Spontaneous Intracranial Hemorrhages in a Community of Asian Americans: Case Series and Literature Review;Cureus;2024-01-11

3. “East Asian Paradox” Revisited: Precision Medicine for Antithrombotic Strategies Tailored to Atherothrombotic Cardiovascular Risks;Journal of Cardiovascular Intervention;2024

4. Ethnic Differences in Thrombotic Profiles of Acute Coronary Syndrome Patients and Relationship to Cardiovascular Outcomes: A Comparison of East Asian and White subjects;Thrombosis and Haemostasis;2023-12-29

5. Efficacy and safety of short-term high dosage dual antiplatelet therapy after 0.6 mg/kg rt-PA intravenous thrombolysis for acute ischemic stroke;Medicine;2023-09-08